Singapore markets open in 8 hours 33 minutes
Straits Times Index
3,287.75 -5.38 (-0.16%) S&P 500
5,027.45 -44.18 (-0.87%) Dow
37,968.01 -492.91 (-1.28%) Nasdaq
15,515.31 -197.44 (-1.26%) Bitcoin USD
64,111.31 -441.37 (-0.68%) CMC Crypto 200
1,386.40 +3.83 (+0.28%)
Agios Pharmaceuticals, Inc. (AGIO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 12:26PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.78B |
| Enterprise value | 1.07B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 65.71 |
| Price/book (mrq) | 2.19 |
| Enterprise value/revenue | 40.07 |
| Enterprise value/EBITDA | -2.79 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.86 |
| 52-week change 3 | 41.89% |
| S&P500 52-week change 3 | 22.64% |
| 52-week high 3 | 35.50 |
| 52-week low 3 | 19.80 |
| 50-day moving average 3 | 29.82 |
| 200-day moving average 3 | 25.52 |
Share statistics
| Avg vol (3-month) 3 | 754.75k |
| Avg vol (10-day) 3 | 717.61k |
| Shares outstanding 5 | 56.19M |
| Implied shares outstanding 6 | 56.44M |
| Float 8 | 47.6M |
| % held by insiders 1 | 1.62% |
| % held by institutions 1 | 108.53% |
| Shares short (15 Apr 2024) 4 | 6.65M |
| Short ratio (15 Apr 2024) 4 | 10.41 |
| Short % of float (15 Apr 2024) 4 | 11.98% |
| Short % of shares outstanding (15 Apr 2024) 4 | 11.84% |
| Shares short (prior month 15 Mar 2024) 4 | 6.85M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,496.23% |
Management effectiveness
| Return on assets (ttm) | -22.49% |
| Return on equity (ttm) | -36.83% |
Income statement
| Revenue (ttm) | 26.82M |
| Revenue per share (ttm) | 0.48 |
| Quarterly revenue growth (yoy) | 64.80% |
| Gross profit (ttm) | N/A |
| EBITDA | -384.86M |
| Net income avi to common (ttm) | -352.09M |
| Diluted EPS (ttm) | -6.33 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 776.93M |
| Total cash per share (mrq) | 13.83 |
| Total debt (mrq) | 72M |
| Total debt/equity (mrq) | 8.88% |
| Current ratio (mrq) | 12.27 |
| Book value per share (mrq) | 14.50 |
Cash flow statement
| Operating cash flow (ttm) | -296.06M |
| Levered free cash flow (ttm) | -215.06M |
© 2024 Yahoo. All rights reserved.